"ＪＲ「東京駅」八重洲口、地下鉄銀座線・東西線「日本橋」駅から5分。内科、腎・高血圧・消化器・肝臓・整形外科・産業医。「働く人のためのクリニック」という、コンセプトのもと2001年より、身近な診療所として仕事の合間にご利用いただいております。"

During the past decade, Nihonbashi Egawa Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nihonbashi Egawa Clinic" are "Crohn's Disease" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Nihonbashi Egawa Clinic" in a lesser frequency.

Most popular intervention types in "Nihonbashi Egawa Clinic" are "Drug" (4 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nihonbashi Egawa Clinic" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Nihonbashi Egawa Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nihonbashi Egawa Clinic, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nihonbashi Egawa Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".